Home
  Healthcare professionals Patients
     Go
Home
Products
Medical Information
Training Centres
Info Centre
Training & Guidance
Technical evaluations
Battery Disposal
Related Articles
Product Brochures
FAQ
Bibliography
Further Links
Events
Contact
 

Info Centre: Bibliography

AuthorTitle Reference
Leichsenring I, Plesch W, Unkrig, V, Newhart A, Kitchen S, Kitchen DP, Mclean R, Dikkeschei B, van den Besselaar AMPHResults of the Master Lot Calibration of a New Coagulation Monitoring System for Patient Self-TestingJ Thromb Haemost 2005; 3 (Suppl 1): P0884
Multicenter Performance Evaluation of the CoaguChek XS SystemEvaluation Report from Roche Diagnostics Available upon request
Ansell J, Jacobson A, Levy J, Völler H, Hasenkam JM: Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulationInternational consensus guidelines prepared by International Self-Monitoring Association for Oral AnticoagulationJ Thromb Haemost 2005; 3 (Suppl 1): P0884
Menéndez-Jándula B, Souto JC, Oliver A, Montserrat I, Quintana M, Gich I, Bonfill X, Fontcuberta JComparing Self-Management of Oral Anticoagulant Therapy with Clinic ManagementAnn Intern Med 2005; 142:1-10.
Taborski U, Wittstamm F-J, Bernardo ACost-effectiveness of self-managed anticoagulant therapy in GermanySem Thromb Hemostas 1999; 25:103-109
Tripodi A, Breukink-Engbers WGM, van den Besselaar AMHPOral Anticoagulant Monitoring by Laboratory or Near-Patient Testing: What a Clinician Should Be Aware OfSem Vasc Med 2003; 3:243-254.
Moll S and Ortel TLMonitoring Warfarin Therapy in Patients with Lupus Anticoagulants Annals of Internal Medicine 1997; 127:177-185.
 World Health Organisation "Annex 3 - Guidelines for Thromboplastins and Plasma used to Control Oral Anticoagulation Therapy" WHOTechnical Report Series 1999; No. 889, pp. 64-93.
J. Hirsh, V. Fuster"Guide to Anticoagulant Therapy Part 2 Oral Anticoagulants" Circulation 199489, pp. 1469-1480.
J. Hirsh, J. Dalen, D. Deykin, L. Poller, H. Bussey "Oral Anticoagulation - Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range." Chest 19954, Supplement "Fourth ACCP Consensus Conference on Antithrombotic Therapy" pp. 231-246
C. Heneghan, P. Alonso-Coello, J. M. Gracia-Alamino, R. Perera, E. Meats, P. Glaszioui"Oral Anticoagulation - Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range”The Lancet 2206; 367:404-11
Performance Evaluation of the CoaguChek XS Plus SystemEvaluation Report from Roche DiagnosticsAvailable upon request
Roche Diagnostics Near Patient Testing, Dr. Winfried Plesch, T. Wolf The CoaguChek XS System - Method Comparisons with Different Laboratory ThromboplastinsAvailable upon request

 
 

 
Last modified: 6 September 2006
 
  Further Links  
 
Medical Information
Further Links
 
© Roche Diagnostics Ltd. 2010 / Legal/Privacy Policy / Disclaimer
  This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.